From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Gold – vaccine No.2 offers just a temporary minor crunch

By Nigel Somerville | Tuesday 17 November 2020


 


The announcement by Pfizer (NYSEPFE) that its Covid vaccine was 90% effective saw markets rally and gold drop sharply – initially by around $100. Yesterday saw vaccine no.2, from Moderna (Nasdaq – MRNA) announced, and the Dow Jones closed at an all-time record. But the effect on gold was much more limited…

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 08:06:03